These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2872825)

  • 21. The effect of haloperidol on serum levels of lithium in adult manic patients.
    Schaffer CB; Batra K; Garvey MJ; Mungas DM; Schaffer LC
    Biol Psychiatry; 1984 Oct; 19(10):1495-9. PubMed ID: 6440599
    [No Abstract]   [Full Text] [Related]  

  • 22. Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol.
    Shopsin B; Gershon S; Thompson H; Collins P
    Arch Gen Psychiatry; 1975 Jan; 32(1):34-42. PubMed ID: 1089401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of lithium/neuroleptic neurotoxicity during lithium maintenance.
    Coffey CE; Ross DR
    Am J Psychiatry; 1980 Jun; 137(6):736-7. PubMed ID: 7377401
    [No Abstract]   [Full Text] [Related]  

  • 25. [A comparative evaluation of the effect of lithium carbonate, haloperidol and preparation IB-503 in the treatment of manic states].
    Nuller IuL; Rabinovich MM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(2):277-83. PubMed ID: 5572074
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse reactions in treatment with lithium carbonate and haloperidol.
    Baastrup PC; Hollnagel P; Sorensen R; Schou M
    JAMA; 1976 Dec; 236(23):2645-6. PubMed ID: 1036539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium encephalopathy: a clinical, psychiatric, and EEG evaluation.
    Fetzer J; Kader G; Danahy S
    Am J Psychiatry; 1981 Dec; 138(12):1622-3. PubMed ID: 6118069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lithium-intoxication masked by neuroleptic drugs in the lithium--saluretic combination (author's transl)].
    Lenz G; König P; Küfferle B
    Nervenarzt; 1977 Nov; 48(11):630-1. PubMed ID: 593476
    [No Abstract]   [Full Text] [Related]  

  • 29. [Has drug treatment of manic disorders changed in clinical routine practice? Retrospective analysis of treatment modalities and results in a university psychiatric clinic].
    Reetz-Kokott U; Müller-Oerlinghausen B
    Nervenarzt; 1996 Mar; 67(3):229-34. PubMed ID: 8901281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurotoxicity related to lithium and neuroleptic combinations? A retrospective review.
    Kessel JB; Verghese C; Simpson GM
    J Psychiatry Neurosci; 1992 Mar; 17(1):28-30. PubMed ID: 1349826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of two adjunctive treatment strategies in acute mania.
    Busch FN; Miller FT; Weiden PJ
    J Clin Psychiatry; 1989 Dec; 50(12):453-5. PubMed ID: 2574719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Benign cranial hypertension secondary to treatment with lithium].
    Moral Iglesias L; O'Neill of Tyrone A; Alvarez Cermeño JC; Fernández JM; Sáiz Ruiz J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1989; 17(4):251-3. PubMed ID: 2572150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic neuroleptic use in manic-depressive illness.
    Sernyak MJ; Woods SW
    Psychopharmacol Bull; 1993; 29(3):375-81. PubMed ID: 7907185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Incompatibility of lithium therapy with neuroleptics. a case report (author's transl)].
    Pühringer W; Kocher R; Gastpar M
    Nervenarzt; 1979 Feb; 50(2):124-7. PubMed ID: 34111
    [No Abstract]   [Full Text] [Related]  

  • 36. The question of lithium/neuroleptic toxicity.
    Jeffries J; Remington G; Wilkins J
    Can J Psychiatry; 1984 Nov; 29(7):601-4. PubMed ID: 6150756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of neuroleptic-resistant mania and schizoaffective disorders.
    De Beaurepaire R
    Am J Psychiatry; 1992 Nov; 149(11):1614-5. PubMed ID: 1357993
    [No Abstract]   [Full Text] [Related]  

  • 38. [Complications observed during use of lithium salt-neuroleptic combinations; comparative study of clinical evolution, EEG and pharmacokinetics].
    Granier F; Girard M; Loustalan JM; Thomas J; Escande M
    Ann Med Psychol (Paris); 1983; 141(8):891-908. PubMed ID: 6141759
    [No Abstract]   [Full Text] [Related]  

  • 39. Valproate in bipolar disorder: the Canadian perspective.
    Joffe RT
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S46-50. PubMed ID: 8098990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for neuroleptic malignant syndrome.
    Akpaffiong MJ
    J Natl Med Assoc; 1992 Sep; 84(9):800-2. PubMed ID: 1404479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.